LOMBARDI, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.509
EU - Europa 1.668
AS - Asia 1.302
SA - Sud America 304
AF - Africa 300
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 18
Totale 8.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.373
IT - Italia 759
SG - Singapore 436
CN - Cina 334
BR - Brasile 199
HK - Hong Kong 166
DE - Germania 123
FI - Finlandia 108
SE - Svezia 92
NL - Olanda 66
FR - Francia 51
IE - Irlanda 45
RU - Federazione Russa 45
VN - Vietnam 44
GB - Regno Unito 41
PL - Polonia 36
AT - Austria 29
ES - Italia 22
IN - India 20
KR - Corea 20
AR - Argentina 19
CA - Canada 18
JP - Giappone 18
TR - Turchia 18
UA - Ucraina 17
ID - Indonesia 16
SK - Slovacchia (Repubblica Slovacca) 16
CI - Costa d'Avorio 15
PY - Paraguay 14
BE - Belgio 13
MA - Marocco 13
UG - Uganda 13
YE - Yemen 13
CR - Costa Rica 12
GF - Guiana Francese 12
GH - Ghana 12
HR - Croazia 12
NZ - Nuova Zelanda 12
PK - Pakistan 12
ZA - Sudafrica 12
AL - Albania 11
BO - Bolivia 11
BZ - Belize 11
CY - Cipro 11
EC - Ecuador 11
EG - Egitto 11
GE - Georgia 11
IR - Iran 11
ML - Mali 11
MX - Messico 11
NO - Norvegia 11
PE - Perù 11
SI - Slovenia 11
AZ - Azerbaigian 10
BA - Bosnia-Erzegovina 10
BG - Bulgaria 10
BW - Botswana 10
CZ - Repubblica Ceca 10
DO - Repubblica Dominicana 10
IQ - Iraq 10
MD - Moldavia 10
PT - Portogallo 10
AE - Emirati Arabi Uniti 9
BD - Bangladesh 9
CG - Congo 9
CH - Svizzera 9
CW - ???statistics.table.value.countryCode.CW??? 9
DK - Danimarca 9
IL - Israele 9
LB - Libano 9
ME - Montenegro 9
NI - Nicaragua 9
RO - Romania 9
SA - Arabia Saudita 9
ZM - Zambia 9
AO - Angola 8
BY - Bielorussia 8
CL - Cile 8
CU - Cuba 8
GR - Grecia 8
HU - Ungheria 8
LA - Repubblica Popolare Democratica del Laos 8
LC - Santa Lucia 8
LV - Lettonia 8
PH - Filippine 8
PS - Palestinian Territory 8
RS - Serbia 8
SN - Senegal 8
TJ - Tagikistan 8
TW - Taiwan 8
TZ - Tanzania 8
UZ - Uzbekistan 8
YT - Mayotte 8
BB - Barbados 7
BF - Burkina Faso 7
BJ - Benin 7
CO - Colombia 7
DJ - Gibuti 7
DZ - Algeria 7
GA - Gabon 7
Totale 7.839
Salva come PNG Salva come JPEG
Città #
Fairfield 653
Ashburn 468
Chandler 414
Woodbridge 395
Houston 323
Ann Arbor 308
Singapore 278
Cambridge 245
Seattle 244
Wilmington 203
Hong Kong 158
Beijing 92
Milan 86
Boardman 78
Helsinki 62
San Diego 60
Santa Clara 60
Des Moines 55
Princeton 51
Padova 47
Medford 45
Bologna 44
Dublin 42
Rome 39
Munich 35
Naples 31
Los Angeles 27
Roxbury 23
Turin 23
Hefei 22
Bytom 21
New York 21
Nanjing 20
Florence 19
Jinan 18
Chicago 17
Nuremberg 17
Jacksonville 16
Abidjan 15
São Paulo 15
Vienna 15
Genoa 14
Turku 14
Brooklyn 13
Council Bluffs 13
Kampala 13
Shenyang 13
Tokyo 13
Falkenstein 12
Bamako 11
Falls Church 11
Frankfurt am Main 11
Nanchang 11
Seoul 11
Accra 10
Baku 10
Redondo Beach 10
San José 10
Bari 9
Buffalo 9
Cayenne 9
Dallas 9
Dong Ket 9
La Paz 9
London 9
Lusaka 9
Tbilisi 9
Auckland 8
Cagliari 8
Cairo 8
Castries 8
Dakar 8
Dar es Salaam 8
Dushanbe 8
Ho Chi Minh City 8
Luanda 8
Managua 8
Parma 8
Podgorica 8
Rimini 8
Sanaa 8
Stockholm 8
Amman 7
Conakry 7
Cotonou 7
Curitiba 7
Dili 7
Hargeisa 7
Havana 7
Hebei 7
Libreville 7
Lima 7
Modena 7
Nouakchott 7
Redwood City 7
Salt Lake City 7
San Francisco 7
Sofia 7
Verona 7
Warsaw 7
Totale 5.332
Salva come PNG Salva come JPEG
Nome #
2-Hydroxyglutarate as a biomarker in glioma patients 831
Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up 239
Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma 225
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 207
Effectiveness of antiangiogenic drugs in glioblastoma patients: A systematic review and meta-analysis of randomized clinical trials 195
5-aminolevulinic Acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns. 188
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 187
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 186
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 185
Early recognition of aggressive pituitary adenomas: a single-centre experience 183
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 171
Multifocal presentation of medulloblastoma in adulthood 168
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: A phase II study with pharmacokinetic analysis 166
5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature 166
Annexin 2A sustains glioblastoma cell dissemination and proliferation 163
Open Transcranial Resection of Small (<35 mm) Meningiomas of the Anterior Midline Skull Base in Current Microsurgical Practice 163
An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab. 162
Predictive value of intraoperative 5-aminolevulinic acid-induced fluorescence for detecting bone invasion in meningioma surgery. 162
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases 158
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma 152
Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma 148
Surgery on motor area metastasis 146
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 143
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis. 141
Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study 141
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 141
Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma 140
Cognitive and emotive state in elderly treatment-naïve patients with advanced cancer compared with an elderly healthy control population 137
Corneal side effects induced by EGFR-inhibitor antibody–drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study 135
An update on targeted therapy in metastatic renal cell carcinoma 134
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab 134
Neoplastic Meningitis from Solid Tumors: New Diagnostic and Therapeutic Approaches 134
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 129
Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma 128
Pegylated Liposomal Doxorubicin and Gemcitabine in Patients With Advanced Hepatocellular Carcinoma Results of a Phase 2 Study 123
DIAGNOSTIC VALUE OF PLASMA AND URINARY 2-HYDROXYGLUTARATE TO IDENTIFY PATIENTS WITH IDH-MUTATED GLIOMA 121
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? 119
Assessing Response Using (99m) Tc-MIBI Early after Interstitial Chemotherapy with Carmustine-Loaded Polymers in Glioblastoma Multiforme: Preliminary Results. 119
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology) 116
Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma 115
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature. 115
Predictive role of MGMT status in recurrent glioblastoma (GBM) patients (PTS) treated with antiangiogenic drug (AD) plus temozolomide (TMZ) or CPT-11 114
Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology). 112
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 111
An Overview of Intracranial Ependymomas in Adults 109
Efficacy and safety of radiotherapy (RT) plus temozolomide (TMZ) in elderly patients (EP) with glioblastoma (GBM) 109
Cilengitide in bevacizumab-refractory high-grade glioma: Two case reports and critical review of the literature 104
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study 95
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 94
Multifocal Medulloblastoma in an Adult Patient: Description of a Rare Presentation and Review of the Literature 93
Newly Diagnosed Multifocal GBM: A Monocentric Experience and Literature Review 89
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E-mutant and SOX2 amplification 80
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care 72
Totale 8.198
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.071
article - articoli 26.542
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021576 0 0 0 45 25 20 34 92 76 149 84 51
2021/2022834 25 54 104 68 82 48 77 94 30 21 60 171
2022/2023789 115 102 25 121 97 118 4 65 80 16 27 19
2023/2024596 24 88 64 38 41 63 52 38 23 28 71 66
2024/20251.703 48 96 102 99 174 81 99 187 121 74 277 345
2025/20261.749 341 456 658 294 0 0 0 0 0 0 0 0
Totale 8.198